VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
about
Type XVIII collagen degradation products in acute lung injuryVascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinomaOpenings between defective endothelial cells explain tumor vessel leakinessThe beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumorsAngiogenesis and Antiangiogenesis in Triple-Negative Breast cancerVascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomasAngiogenic and lymphangiogenic molecules in hematological malignanciesAn essential role for Prox1 in the induction of the lymphatic endothelial cell phenotypeVEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesisBlood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.Specialization of tumour vasculature.Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cellsExpression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis.Lymphatic vessels assessment in feline mammary tumours.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model.Cancer stem cells and tumor metastasis (Review).CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.Angiogenesis in head and neck squamous cell carcinoma.The lymphatic system in health and disease.Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.Angiogenesis and angiogenic mediators in haematological malignancies.Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.Angiogenic molecules and mechanisms in breast cancer.Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.Lymphatic vessels as targets of tumor therapy?Markers for the lymphatic endothelium: in search of the holy grail?Lymphatic versus blood vascular endothelial growth factors and receptors in humans.Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.Lymphatic endothelium: a new frontier of metastasis research.Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.Development of second-generation VEGFR tyrosine kinase inhibitors: current status.Biomarkers for anti-angiogenic therapy in cancer.IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth.Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection
P2860
Q22000109-D826C493-8F69-40F1-8089-6C8F53C68FEEQ24656802-F6023C55-E438-488F-AC66-9ED7C75C2860Q24681507-7EC91F64-4DB5-4BDA-BDF6-8FEAC5212C0EQ24685887-7D1F3C26-7958-40E6-B1E9-BE9F81000834Q28079013-3ACD0C1A-4558-4F1E-86E9-081EFFD4B080Q28200101-D00024CB-C19B-41F3-A2B1-08428336936EQ28211085-0BC256C1-7375-4156-AA7B-FFDE5BCDBC0BQ28216979-2038B1D0-EE9D-4612-8E93-DB18826631C6Q28508584-1E078C95-B91D-4A2C-8A28-0E52EF0DEB0FQ28509472-3E2EE1D1-0DAB-41CB-9A5F-121B6794872BQ30498120-BD66F2C3-4A43-40E1-B088-F667D41F9AC9Q30896811-D97DCA40-36DD-4A74-9AF7-30FB75150CE5Q31079430-D1073CE8-062C-4912-BAD4-0B439F2FA0B2Q33202253-01A8C178-809A-4885-8479-D4C7734A2657Q33269181-3A6EC817-BFDB-4E92-A138-B01AF648192BQ33555154-EB88CCDD-53B1-4165-A240-F8868A6105F3Q33722528-AADDCF5C-32AD-43C9-B7A4-7AD49EE5949AQ33737146-F750A845-4F31-469A-9D8B-32925F856DB1Q33778124-0BDCC0EB-0A71-4336-B2DB-CB6A5F40DAB8Q33788042-DF4FB734-80E9-4835-A35D-E72AE960F279Q34004670-C36D22A5-10AE-4BE3-A9F3-82FB86EAE501Q34015299-6515B09A-B100-4DDB-A930-1A93A266A5E0Q34017710-6577C1C7-2955-4D61-AE24-560A0F8E42AEQ34066152-0FA6D166-55BC-4130-9371-72CA5A47CC4AQ34089126-EBEFF7E7-F99B-472B-B89C-1625C08D943CQ34091556-A00E0DED-B231-4AEB-9144-FF33B62B9682Q34108131-546879D6-B5BC-4E8F-9A45-BBEFB3970A28Q34130552-78483BB6-9E46-4091-9B41-9193B072E10EQ34161479-B37150F7-C953-4FCB-8720-BDF76D6FAC0CQ34372169-B1BBC90E-BAAA-492A-BB4C-78F3A799702DQ34398711-9280C7C1-F072-4C9A-9D58-4BB4DEF6F07DQ34398732-20AC3EB3-D7D1-4A1B-926E-DC28C957651FQ34478521-D6F12FB8-5E15-4FE0-9D42-7F38D4108A6BQ34486406-C6647D25-2565-447C-9B6C-3C9CCD6B01BBQ34608643-47185868-1433-4088-B1A9-E463F89C270CQ34616440-EAB06D0A-F4D8-4719-B9CD-A7DC7A98413BQ34695003-213F0733-CE98-4341-A0D0-07262B52F49AQ34760267-FCEDF3DF-6743-4B3D-BF5E-A272BCB67EFFQ34774917-407F9B73-8ABB-4E9D-8CC4-A72EF0B50CB9Q34916073-B6528812-68C9-4322-8248-F5C99A46C679
P2860
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
@ast
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
@en
type
label
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
@ast
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
@en
prefLabel
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
@ast
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
@en
P2093
P2860
P1476
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
@en
P2093
P Heikkilä
T Pihlajaniemi
P2860
P304
P356
10.1016/S0002-9440(10)65392-8
P407
P50
P577
1999-05-01T00:00:00Z